Stem definition | Drug id | CAS RN |
---|---|---|
antihistaminics | 249 | 68844-77-9 |
Dose | Unit | Route |
---|---|---|
10 | mg | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 0.50 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 0.36 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 2 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 31, 1988 | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | R06AX11 | RESPIRATORY SYSTEM ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE Other antihistamines for systemic use |
CHEBI has role | CHEBI:37955 | H1 receptor antagonists |
CHEBI has role | CHEBI:50857 | anti-allergic drugs |
CHEBI has role | CHEBI:149553 | anticoronaviral drug |
MeSH PA | D018926 | Anti-Allergic Agents |
MeSH PA | D018494 | Histamine Agents |
MeSH PA | D006633 | Histamine Antagonists |
MeSH PA | D006634 | Histamine H1 Antagonists |
MeSH PA | D039563 | Histamine H1 Antagonists, Non-Sedating |
MeSH PA | D018377 | Neurotransmitter Agents |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Allergic rhinitis | indication | 61582004 | |
Sneezing | indication | 76067001 | |
Chronic idiopathic urticaria | indication | 302162004 | |
Allergic conjunctivitis | indication | 473460002 | DOID:11204 |
Urticaria | off-label use | 126485001 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 8.47 | Basic |
pKa2 | 5.81 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Histamine H1 receptor | GPCR | ANTAGONIST | A2 | 8.58 | WOMBAT-PK | SCIENTIFIC LITERATURE | |||
Beta-1 adrenergic receptor | GPCR | Ki | 5.00 | DRUG MATRIX | |||||
Mu-type opioid receptor | GPCR | Ki | 6.22 | DRUG MATRIX | |||||
D(1A) dopamine receptor | GPCR | Ki | 5.70 | DRUG MATRIX | |||||
D(2) dopamine receptor | GPCR | Ki | 5.82 | DRUG MATRIX | |||||
Alpha-2A adrenergic receptor | GPCR | Ki | 5.74 | DRUG MATRIX | |||||
Sigma non-opioid intracellular receptor 1 | Membrane receptor | Ki | 6.03 | DRUG MATRIX | |||||
Potassium voltage-gated channel subfamily H member 2 | Ion channel | IC50 | 9.05 | WOMBAT-PK | |||||
Cytochrome P450 3A4 | Enzyme | IC50 | 5.48 | WOMBAT-PK | |||||
Multidrug resistance protein 1 | Transporter | IC50 | 6.05 | WOMBAT-PK | |||||
Sodium-dependent serotonin transporter | Transporter | Ki | 6.16 | DRUG MATRIX | |||||
Sodium-dependent noradrenaline transporter | Transporter | Ki | 5.87 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 1A | GPCR | Ki | 6.36 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2A | GPCR | Ki | 8.25 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2B | GPCR | Ki | 8.13 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2C | GPCR | Ki | 7.03 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 6 | GPCR | Ki | 5.82 | DRUG MATRIX | |||||
Alpha-2B adrenergic receptor | GPCR | Ki | 5.76 | DRUG MATRIX | |||||
D(3) dopamine receptor | GPCR | Ki | 6.83 | DRUG MATRIX | |||||
Histamine H2 receptor | GPCR | Ki | 5.78 | DRUG MATRIX | |||||
Histamine H4 receptor | GPCR | Ki | 5.10 | CHEMBL | |||||
Muscarinic acetylcholine receptor M1 | GPCR | Ki | 6.59 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M2 | GPCR | Ki | 6.30 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M3 | GPCR | Ki | 6.75 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M4 | GPCR | Ki | 6.59 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M5 | GPCR | Ki | 6.30 | DRUG MATRIX | |||||
Beta-3 adrenergic receptor | GPCR | Ki | 5.22 | DRUG MATRIX | |||||
Alpha-2C adrenergic receptor | GPCR | Ki | 6.55 | DRUG MATRIX | |||||
Sodium-dependent dopamine transporter | Transporter | Ki | 6.10 | DRUG MATRIX | |||||
Adenosine receptor A3 | GPCR | Ki | 4.78 | DRUG MATRIX | |||||
D(4) dopamine receptor | GPCR | Ki | 5.67 | DRUG MATRIX | |||||
Alpha-1D adrenergic receptor | GPCR | Ki | 8.00 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 3A | Ion channel | Ki | 7.02 | DRUG MATRIX | |||||
Kappa-type opioid receptor | GPCR | Ki | 5.58 | DRUG MATRIX | |||||
ATP-binding cassette sub-family G member 2 | Transporter | WOMBAT-PK | |||||||
Glycine receptor subunit alpha-1 | Ion channel | EC50 | 5.38 | CHEMBL | |||||
Calmodulin | Cytosolic other | IC50 | 6 | WOMBAT-PK | |||||
Delta-type opioid receptor | GPCR | Ki | 5.34 | DRUG MATRIX | |||||
Somatostatin receptor type 5 | GPCR | Ki | 5.39 | CHEMBL | |||||
Epidermal growth factor receptor | Kinase | IC50 | 5.22 | DRUG MATRIX | |||||
Substance-P receptor | GPCR | Ki | 5.07 | DRUG MATRIX | |||||
Tyrosine-protein kinase Lck | Kinase | IC50 | 4.70 | DRUG MATRIX | |||||
Tyrosine-protein kinase Fyn | Kinase | IC50 | 5.55 | DRUG MATRIX | |||||
Receptor tyrosine-protein kinase erbB-2 | Kinase | IC50 | 4.88 | DRUG MATRIX | |||||
Substance-K receptor | GPCR | Ki | 6.00 | DRUG MATRIX | |||||
Potassium voltage-gated channel subfamily H member 1 | Ion channel | BLOCKER | IC50 | 6.70 | IUPHAR | ||||
Melanocortin receptor 4 | GPCR | Ki | 4.87 | DRUG MATRIX | |||||
Melanocortin receptor 5 | GPCR | Ki | 5.67 | DRUG MATRIX | |||||
Melanocortin receptor 3 | GPCR | Ki | 4.87 | DRUG MATRIX | |||||
Sodium/nucleoside cotransporter 1 | Transporter | Ki | 5.31 | DRUG MATRIX | |||||
Multidrug and toxin extrusion protein 1 | Transporter | IC50 | 4.58 | CHEMBL | |||||
Polycomb protein EED | Unclassified | IC50 | 4.03 | CHEMBL | |||||
HLA class I histocompatibility antigen, A-3 alpha chain | Unclassified | Kd | 5.60 | CHEMBL | |||||
Transmembrane protein 97 | Enzyme | Ki | 7.02 | CHEMBL | |||||
Nuclear receptor subfamily 4 group A member 2 | Nuclear other | Kd | 4 | CHEMBL | |||||
Alpha-1B adrenergic receptor | GPCR | Ki | 7.02 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 1B | GPCR | Ki | 6.20 | DRUG MATRIX | |||||
Membrane-associated progesterone receptor component 1 | Membrane receptor | Ki | 6.73 | DRUG MATRIX | |||||
Alpha-1A adrenergic receptor | GPCR | IC50 | 7.62 | CHEMBL | |||||
Protein farnesyltransferase | Enzyme | IC50 | 8.70 | CHEMBL | |||||
5-hydroxytryptamine receptor 1A | GPCR | IC50 | 6.12 | CHEMBL |
ID | Source |
---|---|
4019379 | VUID |
N0000147536 | NUI |
D00234 | KEGG_DRUG |
202818 | RXNORM |
C0085170 | UMLSCUI |
CHEBI:2896 | CHEBI |
XB7 | PDB_CHEM_ID |
CHEMBL296419 | ChEMBL_ID |
CHEMBL61301 | ChEMBL_ID |
D016589 | MESH_DESCRIPTOR_UI |
DB00637 | DRUGBANK_ID |
2603 | IUPHAR_LIGAND_ID |
4755 | INN_ID |
7HU6337315 | UNII |
2247 | PUBCHEM_CID |
4224 | MMSL |
768 | MMSL |
d00794 | MMSL |
387333002 | SNOMEDCT_US |
59456005 | SNOMEDCT_US |
4019379 | VANDF |
003413 | NDDF |
None